Argus
•
Apr 08, 2026
KRYS: Raising target price to $290.00
Summary
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve t
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
APLS: What does Argus have to say about APLS?
Apr 29, 2026
•
APLS
PTGX: Lowering target price to $106.00
Apr 29, 2026
•
PTGX
Analyst Report: argenx SE
Apr 24, 2026
•
ARGX
APLS: What does Argus have to say about APLS?
Apr 22, 2026
•
APLS
PTGX: Raising target price to $111.00
Apr 22, 2026
•
PTGX
